AtaiBeckley (ATAI) Tax Provisions (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Tax Provisions of $20000.0 for Q1 2026, down 87.18% year-over-year from $156000.0 in Q1 2025, and down 87.18% quarter-over-quarter from $156000.0 in Q1 2025.
AtaiBeckley (ATAI) Tax Provisions (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Tax Provisions for 6 years, with the latest figure at $100000.0 in Q3 2025.
- Quarterly Tax Provisions fell 50.0% year-over-year to $100000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $163000.0 (down 74.65% YoY) and the FY2024 annual result came in at -$356000.0, down 135.04% from the prior year.
- Tax Provisions for Q1 2026 stood at $20000.0, down from $156000.0 in the prior quarter.
- The five-year high for Tax Provisions was $156000.0 in Q1 2025, with the low at $20000.0 in Q1 2026.
- A 5-year average of $197736.8 and a median of $100000.0 in 2022 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2021 and 2024: Tax Provisions surged 9900.0% in 2021, then tumbled 145.09% in 2024.
- Over 5 years, Tax Provisions stood at $717000.0 in 2021, then soared by 33.19% to $955000.0 in 2022, then sank by 55.18% to $428000.0 in 2023, then sank by 145.09% to -$193000.0 in 2024, then surged by 151.81% to $100000.0 in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered $100000.0, $100000.0, and $156000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | AtaiBeckley | 2.69 Bn | 2.69 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | -193,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 428,000.00 |
| Sep 30, 2023 | 238,000.00 |
| Jun 30, 2023 | 185,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 955,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 717,000.00 |
| Sep 30, 2021 | 400,000.00 |